ASO
ASO Practice Guideline Series: Management of Colorectal Peritoneal Metastases
Abstract
Colorectal peritoneal metastases (CRPM) represent a significant treatment challenge for patients with colorectal cancer that significantly impact quality of life and limit survival.
Systemic chemotherapy represents the current mainstay of management for metastatic disease, but the use of cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is being established as a promising option with survival benefit for select patients.
Identifying best management practices for patients with CRPM is critical as intervention with CRS/HIPEC can carry significant risks of morbidity and mortality.
This guideline report aims to summarize the existing literature regarding optimal management of patients with CRPM and current areas of ongoing investigation.
Source and rights
Published by Annals of surgical oncology, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- ASO
- Published
- 2025
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Annals of surgical oncology
- PubMed
More in oncology
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
